This opportunity is no longer accepting applications.
grant PAR-21-133

First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders (U01 Clinical Trial Required)

This grant opportunity aims to fund early stage clinical trials for new drugs or devices targeting psychiatric disorders with unmet needs. It supports trials in both children and adults, focusing on safety, brain exposure, and effectiveness. The goal is to gather data to reduce the risks for further drug or device development and to attract additional funding. The grant emphasizes collaboratio…

The purpose of this Funding Opportunity Announcement (FOA) is to encourage cooperative agreement applications to support early stage clinical trials of novel mechanism of action, investigational drugs, or novel neuromodulatory devices for the treatment of psychiatric disorders in areas of unmet …

Funding Source

Agency: National Institutes of Health
Program: SBIR

Dates

Submission Deadline: October 15, 2024
Application Window Closes: October 15, 2024
Opportunity Released: March 2, 2021
Open for Submission: March 2, 2021

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.